Patents by Inventor Eileen Frances Murphy

Eileen Frances Murphy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIFIDOBACTERIUM LONGUM NCIMB 41676
    Publication number: 20230414681
    Abstract: Bifidobacterium longum strain NCIMB 41676 is useful for improving or sustaining vitality and/or reducing mental fatigue in stressful situations.
    Type: Application
    Filed: August 24, 2023
    Publication date: December 28, 2023
    Applicant: PrecisionBiotics Group Limited
    Inventors: Eileen Frances MURPHY, Paul ENCK, Christoph BRAUN, Huiying WANG
  • COMBINATION PRODUCT FOR PROPHYLAXIS AND TREATMENT OF IRRITABLE BOWEL SYNDROME
    Publication number: 20230405061
    Abstract: A combination product comprising an isolated strain of Bifidobacterium NCIMB 41003 and another strain which does not adversely interact with Bifidobacterium NCIMB 41003 improves gastrointestinal symptoms associated with IBS and improves one or more of mood, stress, anxiety, sleep quality and depression associated with IBS.
    Type: Application
    Filed: July 14, 2023
    Publication date: December 21, 2023
    Applicant: PRECISIONBIOTICS GROUP LIMITED
    Inventors: Barry KIELY, Eileen Frances MURPHY, David GROEGER
  • NCIMB 41676
    Patent number: 11771723
    Abstract: Bifidobacterium longum strain NCIMB 41676 is useful for improving or sustaining vitality and/or reducing mental fatigue in stressful situations.
    Type: Grant
    Filed: January 29, 2019
    Date of Patent: October 3, 2023
    Assignee: PrecisionBiotics Group Limited
    Inventors: Eileen Frances Murphy, Paul Enck, Christoph Braun, Huiying Wang
  • COMBINATION PRODUCT FOR PROPHYLAXIS AND TREATMENT OF IRRITABLE BOWEL SYNDROME
    Publication number: 20220387523
    Abstract: A combination product comprising an isolated strain of Bifidobacterium NCIMB 41003 and another strain which does not adversely interact with Bifidobacterium NCIMB 41003 improves gastrointestinal symptoms associated with IBS and improves one or more of mood, stress, anxiety, sleep quality and depression associated with LBS.
    Type: Application
    Filed: June 17, 2022
    Publication date: December 8, 2022
    Applicant: PRECISIONBIOTICS GROUP LIMITED
    Inventors: Barry KIELY, Eileen Frances Murphy, David Groeger
  • for treating obesity and associated metabolic disorders
    Patent number: 11490643
    Abstract: The strain Lactobacillus casei AH077 (NCIMB12019) produces a polysaccharide and increases energy excretion. The strain acts to block fat absorption and is used in the prevention or treatment of obesity and obesity-related metabolic syndrome.
    Type: Grant
    Filed: March 30, 2021
    Date of Patent: November 8, 2022
    Assignee: PrecisionBiotics Group Limited
    Inventors: Barry Kiely, Eileen Frances Murphy, Selena Healy
  • Combination product for prophylaxis and treatment of irritable bowel syndrome
    Patent number: 11400123
    Abstract: A combination product comprising an isolated strain of Bifidobacterium NCIMB 41003 and another strain which does not adversely interact with Bifidobacterium NCIMB 41003 improves gastrointestinal symptoms associated with IBS and improves one or more of mood, stress, anxiety, sleep quality and depression associated with IBS.
    Type: Grant
    Filed: January 29, 2019
    Date of Patent: August 2, 2022
    Assignee: PrecisionBiotics Group Limited
    Inventors: Barry Kiely, Eileen Frances Murphy, David Groeger
  • PROBIOTIC BIFIDOBACTERIUM STRAIN
    Publication number: 20220169976
    Abstract: Probiotic Bifidobacterium strain AH1714 is significantly immunomodulatory following oral consumption. The strain is useful as an immunomodulatory biotherapeutic agent.
    Type: Application
    Filed: December 8, 2021
    Publication date: June 2, 2022
    Applicant: PRECISIONBIOTICS GROUP LIMITED
    Inventors: Liam O'Mahony, Barry Kiely, John Francis Cryan, Timothy Dinan, Eileen Frances Murphy
  • Probiotic strain
    Patent number: 11225641
    Abstract: Probiotic Bifidobacterium strain AH1714 is significantly immunomodulatory following oral consumption. The strain is useful as an immunomodulatory biotherapeutic agent.
    Type: Grant
    Filed: February 13, 2020
    Date of Patent: January 18, 2022
    Assignee: PrecisionBiotics Group Limited
    Inventors: Liam O'Mahony, Barry Kiely, John Francis Cryan, Timothy Dinan, Eileen Frances Murphy
  • LACTOBACILLUS CASEI FOR TREATING OBESITY AND ASSOCIATED METABOLIC DISORDERS
    Publication number: 20210282444
    Abstract: The strain Lactobacillus casei AH077 (NCIMB12019) produces a polysaccharide and increases energy excretion. The strain acts to block fat absorption and is used in the prevention or treatment of obesity and obesity-related metabolic syndrome.
    Type: Application
    Filed: March 30, 2021
    Publication date: September 16, 2021
    Applicant: PrecisionBiotics Group Limited
    Inventors: Barry KIELY, Eileen Frances MURPHY, Selena HEALY
  • BIFIDOBACTERIUM LONGUM NCIMB 41676
    Publication number: 20210127695
    Abstract: Bifidobacterium longum strain NCIMB 41676 improves sleep.
    Type: Application
    Filed: September 4, 2020
    Publication date: May 6, 2021
    Applicants: PrecisionBiotics Group Limited, University College Cork - National University of Ireland, Cork
    Inventors: Eileen Frances MURPHY, David GROEGER, Timothy DINAN, John CRYAN
  • for treating obesity and associated metabolic disorders
    Patent number: 10973862
    Abstract: Bifidobacterium longum AH1362 (NCIMB 41715) produces a polysaccharide and increases energy excretion. The strain is used in the prevention or treatment of obesity and obesity-related metabolic syndrome.
    Type: Grant
    Filed: December 9, 2016
    Date of Patent: April 13, 2021
    Assignee: PrecisionBiotics Group Limited
    Inventors: Barry Kiely, Eileen Frances Murphy, Selena Healy
  • BIFIDOBACTERIUM LONGUM NCIMB 41676
    Publication number: 20200375204
    Abstract: A composition comprises live cells of Bifidobacterium longum NCIMB 41676 and a plurality of B vitamins selected from B1, B2, B3, B5, B6, B7, B9 and B12.
    Type: Application
    Filed: January 29, 2019
    Publication date: December 3, 2020
    Inventor: Eileen Frances MURPHY
  • BIFIDOBACTERIUM LONGUM NCIMB 41676
    Publication number: 20200368296
    Abstract: Bifidobacterium longum strain NCIMB 41676 is useful for improving or sustaining vitality and/or reducing mental fatigue in stressful situations.
    Type: Application
    Filed: January 29, 2019
    Publication date: November 26, 2020
    Inventors: Eileen Frances MURPHY, Paul ENCK, Christoph BRAUN
  • NCIMB 41676
    Patent number: 10813366
    Abstract: Methods of treating a subject by administering Bifidobacterium longum strain NCIMB 41676 are discussed. The method may include orally administering a formulation comprising Bifidobacterium longum strain NCIMB 41676 to improve sleep.
    Type: Grant
    Filed: February 18, 2020
    Date of Patent: October 27, 2020
    Assignees: PrecisionBiotics Group Limited, University College Cork—National University of Ireland, Cork
    Inventors: Eileen Frances Murphy, David Groeger, Timothy Dinan, John Cryan
  • PROBIOTIC BIFIDOBACTERIUM STRAIN
    Publication number: 20200325548
    Abstract: Probiotic Bifidobacterium strain AH1714 is significantly immunomodulatory following oral consumption. The strain is useful as an immunomodulatory biotherapeutic agent.
    Type: Application
    Filed: February 13, 2020
    Publication date: October 15, 2020
    Applicant: PRECISIONBIOTICS GROUP LIMITED
    Inventors: Liam O'MAHONY, Barry KIELY, John Francis CRYAN, Timothy DINAN, Eileen Frances MURPHY
  • A COMBINATION PRODUCT FOR PROPHYLAXIS AND TREATMENT OF IRRITABLE BOWEL SYNDROME
    Publication number: 20200289587
    Abstract: A combination product comprising an isolated strain of Bifidobacterium NCIMB 41003 and another strain which does not adversely interact with Bifidobacterium NCIMB 41003 improves gastrointestinal symptoms associated with IBS and improves one or more of mood, stress, anxiety, sleep quality and depression associated with IBS.
    Type: Application
    Filed: January 29, 2019
    Publication date: September 17, 2020
    Inventors: Barry KIELY, Eileen Frances MURPHY, David GROEGER
  • BIFIDOBACTERIUM LONGUM NCIMB 41676
    Publication number: 20200289588
    Abstract: Bifidobacterium longum strain NCIMB 41676 is useful for counter-regulating social rejection/ostracism and/or for improving coping skills.
    Type: Application
    Filed: January 29, 2019
    Publication date: September 17, 2020
    Inventors: Eileen Frances MURPHY, Paul ENCK, Christoph BRAUN
  • BIFIDOBACTERIUM LONGUM NCIMB 41676
    Publication number: 20200214308
    Abstract: Bifidobacterium longum strain NCIMB 41676 improves sleep.
    Type: Application
    Filed: February 18, 2020
    Publication date: July 9, 2020
    Inventors: Eileen Frances MURPHY, David Groeger, Timothy Dinan, John Cryan
  • BIFIDOBACTERIUM LONGUM
    Publication number: 20200115685
    Abstract: A formulation comprising an ingestible carrier and an isolated strain of Bifidobacterium longum.
    Type: Application
    Filed: November 8, 2019
    Publication date: April 16, 2020
    Applicant: Alimentary Health Ltd.
    Inventors: Jose Carlos GARCIA-GARCIA, Michael John Janusz, Barry Kiely, Eileen Frances Murphy, Liam O'Mahony
  • Probiotic bifidobacterium strain
    Patent number: 10597739
    Abstract: Probiotic Bifidobacterium strain AH1714 is significantly immunomodulatory following oral consumption. The strain is useful as an immunomodulatory biotherapeutic agent.
    Type: Grant
    Filed: March 27, 2018
    Date of Patent: March 24, 2020
    Assignee: PrecisionBiotics Group Limited
    Inventors: Liam O'Mahony, Barry Kiely, John Francis Cryan, Timothy Dinan, Eileen Frances Murphy